| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.004 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |